Anxiety disorders affect approximately 19% of US adults annually, making them the most common mental health conditions. Despite this prevalence, anxiety research has lagged depression in producing novel mechanisms — most approved treatments are SSRIs, SNRIs, or benzodiazepines, with the latter limited by addiction concerns. Recent research has expanded into psychedelic-assisted therapy, novel anxiolytic mechanisms, and digital therapeutics. For patients with anxiety, clinical trials for anxiety may offer access to emerging therapies. This guide covers how to find anxiety trials, active research areas, eligibility considerations, and resources.
Categories of anxiety trials
Active anxiety trials in 2026 include:
Psychedelic-assisted therapy: Psilocybin trials for various anxiety disorders, MDMA-assisted therapy specifically for PTSD (covered separately), other psychedelics for anxiety in cancer patients and other populations.
Novel anxiolytic mechanisms: Neurosteroids, GABA-A subunit-selective compounds, kappa opioid receptor antagonists, glutamate modulators, and other approaches that don’t share addiction concerns of benzodiazepines.
Cannabinoids: CBD and other cannabinoid trials for anxiety; specific CBD formulations.
Digital therapeutics: App-based cognitive-behavioral therapy programs, virtual reality exposure therapy.
Specific anxiety disorder subtypes: Trials specific to generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, specific phobias.
Where to find anxiety trials
Resources:
- ClinicalTrials.gov
- Anxiety and Depression Association of America (ADAA)
- NAMI
- Major academic psychiatry programs
- NIMH research initiatives
Subtype considerations
Anxiety trials are often subtype-specific:
Generalized anxiety disorder (GAD): Most common anxiety disorder; most trial activity. Standard treatments include SSRIs, SNRIs, buspirone.
Panic disorder: Recurrent panic attacks; trials test SSRIs, novel mechanisms, and exposure-based therapies.
Social anxiety disorder: Fear of social judgment; trials test traditional and novel mechanisms plus targeted therapy approaches.
Specific phobias: Targeted trials often using exposure therapy or VR-based interventions.
Anxiety in medical contexts: Trials for anxiety in cancer patients, post-surgical anxiety, etc.
Typical eligibility for anxiety trials
Common inclusion criteria:
- Specific anxiety disorder diagnosis (GAD, panic disorder, etc.)
- Severity in specified range (Hamilton Anxiety, GAD-7, or other scales)
- Adequate duration of symptoms
- Stable concurrent medications
Common exclusion criteria:
- Bipolar disorder, psychosis
- Severe depression with active suicidality
- Active substance use disorder
- Specific medical conditions
- Pregnancy
Frequently Asked Questions
Are non-SSRI anxiety options being tested?
Yes. Novel mechanisms including neurosteroids, kappa opioid antagonists, and others are in development.
Can I be in an anxiety trial while on benzodiazepines?
Often no, due to interaction with study assessments and treatment. Some trials require benzodiazepine washout.
Are CBD trials for anxiety legitimate?
Academic and pharma-led CBD trials for anxiety are legitimate research. Be cautious of unregulated CBD products with anxiety claims outside formal trials.
Are virtual reality therapy trials available?
Yes for specific phobias and social anxiety. VR-based exposure therapy is an active research area.
How does anxiety trial structure differ from depression?
Similar overall — baseline assessment, treatment, follow-up. Specific scales differ. Many trials enroll patients with both anxiety and depression given high comorbidity.
The bottom line on anxiety trials
Anxiety trials are expanding with psychedelic, novel mechanism, and digital therapeutic approaches. Subtype-specific matching matters. Discuss with your psychiatrist as part of treatment planning.